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In this paper, carboxyl-ferrocene (Fc-COOH) was explored to label alphafetoprotein antibody (anti-AFP), 
which was then mixed with AU nanoparticles (nano-Au) and multi-walled carbon nanotubes (MWCNTs) 
dispersed by chitosan (CS) to form the nano-Au/MWCNTs/anti-AFP-Fc chitosan composite. After that, 
the composite was immobilized onto the surface of the electrode to prepare a reagentless 
amperometric alphafetoprotein (AFP) immunosensor. The experimental results indicated that, the 
proposed immunosensor had good current response to AFP with a linear range from 0.1 to 50 ng/ml 
with a detection limit of 0.03 ng/ml. Moreover, the electrochemical properties and performance were 
investigated by the cyclic voltammetry. The results also found that, the immunosensor owned the 
advantages of high stability, simple preparation and operation and well regeneration performance.  
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Alphafetoprotein (AFP) is the most reliable and widely 
used tumor marker. The detection of serum AFP level 
plays an important role in the diagnosis, management 
and predicting relapse of germ cell tumors and original 
liver carcinoma (Wang et al., 1999; Bad er et al., 2004.). 
Generally, enzyme-linked immunosorbent assay (ELISA) 
or immunoradiometric assay (IRMA) are the conventional 
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N-(3-dimethylaminopropyl)-N′-ethylcarbodiimidehydrochloride; 
NHS, N-hydroxy succinimide; BSA, bovine serum albumin; 
PBS, phosphate buffered solution; CVD, chemical vapor 
deposition; SCE, saturated calomel reference electrode. 
Kumakura et al.,1983.). This is due to their less 
sensitivity, time-consuming or radiation hazards, 
complicated wash procedure and expensiveness. Due to 
the specific, simple and direct detection techniques and 
reduction in size, cost and time of analysis compared with 
conventional immunoassay techniques, electrochemical 
immunosensors are of great interest for AFP 
determination (Zhuo et al., 2009.). 
Since the importance of immunoreagent immobilization 
onto the electrode surface for the immunosensor 
construction of an electrochemical, searching for an 
effective and simple immobilization method is of 
considerable interest (Ramanan et al., 2010), multi-
walled carbon nanotubes (MWCNTs) are one of the most 
promising candidates for immunoreagent immobilization 
due to their high porosity and surface area, strong 
adsorption capacity and well-defined electrical properties 
(Kaminishi et al., 2005; Ji et al., 2010). It is reported that 
the high surface free energy and existence of inter-tube 
van der Waals forces may lead to aggregation, which 
limited their further development in nanodevices 





possesses many advantages such as excellent 
membrane-forming ability, high permeability towards 
water, good adhesion, biocompatibility and high 
mechanical strength. More importantly, CS can act as a 
scaffold for dispersing MWCNTs and incorporating firmly 
MWCNTs and biomolecules at electrode surface. Thus, 
MWCNTs/CS composite has been explored as platforms 
for the development of an electrochemical immunosensor. 
Herein, alphafetoprotein antibody (anti-AFP) was first 
labeled with carboxyl-ferrocene (Fc-COOH) via N-(3-
dimethylaminopropyl)-N′- ethylcarbodiimidehydrochloride 
(EDC) and N-hydroxy succinimide (NHS) as link reagent. 
Then, it was mixed with Au nanoparticles (nano-Au) and 
MWCNTs/CS composite to form the anti-AFP-Fc/nano-
Au/MWCNTs/CS well-distributed suspension. Next, the 
obtained composite was dropped onto the surface of the 
electrode to prepare a reagentless AFP immunosensor, 
that got rid of the addition of substrates or mediators to 
the analytic solution. The resulting immunosensor was 
tested for its response to AFP by cyclic voltammetry. The 
analytical parameters of the biosensor as well as its 




MATERIALS AND METHODS 
 
Reagent and chemicals  
 
Anti-AFP (0.312 µg/ml) and AFP were purchased from Biocell 
Company (Zhengzhou, China). The MWCNTs (>95% purity) 
synthesized by the chemical vapor deposition (CVD) method were 
purchased from Chengdu Organic Chemicals Co. Ltd., of the 
Chinese Academy of Science. The carboxyl-ferrocene (Fc-COOH), 
chitosan (low molecular weight from the shrimp shell with a degree 
of deacetylation of 83.3%), gold chloride (HAuCl4), bovine serum 
albumin (BSA, 96 to 99%), N-hydroxy succinimide (NHS) and N-(3-
dimethylaminopropyl)-N′-ethylcarbodiimidehydrochloride (EDC) and 
sodium citrate were obtained from Sigma-Aldrich Co. (St. Louis, 
MO, USA) and used without further purification. The 0.1M 
phosphate buffers (PBS) were prepared by mixing stock standard 
solution of K2HPO4 and KH2PO4 and adjusting the pH with KOH. 
The common chemicals were of analytical grade and used as 
received. Double distilled water was used throughout this 
experiment. The nano-Au were prepared as described in the 
literature (Brown et al., 2000) with sodium citrate as reducing agent 
and the obtained nano-Au were stored in a dark bottle at 4°C. 
 
 
Apparatus and measurements 
 
The electrochemical measurements were performed with CH 
instruments CHI 660C electrochemical analyzer/workstation 
(Shanghai CH instrumentation, China) with a three-electrode 
system, which composed of a platinum wire counter electrode, a 
saturated calomel reference electrode (SCE)  and modified gold 
electrode (Au, diameter 4 mm) for the measurement. All potentials 
are referred to the SCE reference electrode. All electrochemical 
experiments were carried out at room temperature. The scanning 
electron micrographs were taken with a scanning electron 
microscope (SEM, S-4800, Hitachi, Tokyo, Japan). The pH 
measurements were made with a pH meter (MP 230, Mettler-
Toledo, Switzerland) and a digital ion analyzer (Model PHS-3C,  
Dazhong instruments, Shanghai, China). 




Preparation of gold nanoparticles 
 
Gold nanoparticles (nano-Au) was prepared by reducing HAuCl4 
using trisodium citrate according to the literature (Grabar et al., 
1995) with a slight modification. First of all, the glassware used to 
prepare nano-Au were cleaned using freshly prepared aqua regia 
(HCl/HNO3 = 3:1) and rinsed thoroughly with doubly distilled water. 
Then, 1 ml 1% (w/v) HAuCl4·4H2O solution was added in 250 ml 
doubly distilled water. Until the mixture solution was heated to a 
rolling boil, 2.5 ml of 1% (w/v) sodium citrate solution was quickly 
added to obtained a red wine nano-Au solution, which was then, 
cooled and stored in a dark glass bottle at 4°C before use. 
 
 
Fabrication of the MWCNTs and Fc labeled anti-AFP 
 
Prior to use, the MWCNTs were pretreated as follow (Shobha et al., 
2008; Luo et al., 2006). Briefly, 25 mg MWCNTs were heated in air 
at 600°C for 2 h and then, soaked in 6 M HCl solution for 24 h and 
centrifuged. Then, the MWCNT were chemically functionalized by 
sonification treatment in a mixture of sulfuric acid and nitric acid 
(3:1) for 6 h at room temperature, then, washed with deionized 
water until the pH of the supernatant was 7.0; finally dried under at 
60°C overnight for further use. 
A 1.0 wt.% CS solution was prepared by dissolving 0.5 g of CS 
into 50 ml of 1.0% acetic acid solution and intermittently sonicated 
for 2 h to obtain a homogeneous solution at room temperature. 
Then, its pH was adjusted to 5.0 using concentrated NaOH 
solutions. Next, 2 ml of the prepared nano-Au and 2 mg pretreated 
MWCNTs were dispersed in 2 ml 1 wt.% CS solutions with the aid 
of ultrasonic agitation for 1 h to obtain a well-distributed 
suspension. 
Fc labeled anti-AFP was obtained by the employment the 
EDC/NHS as coupling agents. 2 mM EDC and 5 mM NHS were 
added into 5 mM Fc solution for activating the carboxyl of Fc under 
continuous stirring for 4 h at room temperature. The 0.4 ml as-
prepared activated Fc was mixed with 0.6 ml anti-AFP for 4 h at 4°C 
for stirring by the formation of an amide link between the carboxyl of 
ferrocenemonocarboxylic and the amino of anti-AFP (anti-AFP-Fc). 
 
 
Electrode modification procedure 
 
Prior to the surface modification, the bare gold electrode was 
polished first with alumina slurry (followed by 0.3 and 0.05 µm) 
then, cleaned by sequential ultrasonic cleaning in redistilled water, 
acetone and ethanol for 5 min each and dried in air. Subsequently, 
the gold electrode was cleaned with piranha solution 
(H2SO4/H2O2=7:3) and rinsed thoroughly with doubly distilled water 
and dried in air.  
0.5 ml of the prepared anti-AFP-Fc was added into 2 ml nano-
Au/MWCNTs/CS composite solutions. After that, the mixture was 
stirred for 12 h and stored at 4°C for further use. The cleaned gold 
electrode surface was covered with 10.0 µl anti-AFP-Fc/nano-
Au/MWCNTs/CS mixture and stored at 4°C overnight. In order to 
remove the unbound antibodies, the anti-AFP-Fc/nano-
Au/MWCNTs/CS composite modified electrode was slow dipping 
into a PBS buffer (pH 7.4) three times. Then, 1% BSA-PBS was 
incubated with the anti-AFP-Fc/nano-Au/MWCNTs/CS electrode for 
20 min to block the unreacted and non-specific sites. Finally, the 
electrode was thoroughly rinsed with deionized water and dried in 
air. The schematic principle for fabrication of this immunosensor 
and the SEM of the anti-AFP-Fc, nano-Au and MWCNTs-CS nano-





Cyclic voltammetric (CV)  experiments  were  performed  on  a  CHI  






Figure 1. Schematic representation of construction of the immunosensor: (a) Formation of anti-AFP-Fc/nano-Au/MWCNTs/CS 






Figure 2. Cyclic voltammograms of different electrodes in PBS (pH 
= 7.0) at a scan rate of 50 mV/s. (a) bare gold electrode, (b) anti-
AFP-Fc/nano-Au/MWCNTs/CS composite membrane modified 
electrode, (c) the modified electrode blocked with BSA and (d) the 




660 C electrochemical workstation with a three-electrode system 
and the potential swept from -0.1 to 0.7 V (vs. SCE) with a 
sweeping rate of 50 mV/s in 4 ml 0.1 M PBS buffer solution (pH 7.0) 
containing 0.1 M KCl at room temperature. The proposed method is 
based on direct immunoassay. The oxidation peak current of CV 
measurement in PBS was recorded as amperometric response. 
When AFP was bound with anti-AFP immobilized on the electrode, 
the antigen-antibody immunocomplex may coat on the surface of 
the electrode inhibiting the electron-transfer, resulting a in decrease 
in amperometric response. Therefore, the amperometric response 
changed proportional to the concentration of AFP after the antibody-
antigen reaction. 
RESULTS AND DISCUSSION 
 
Cyclic voltammetric characterization of modified gold 
electrode 
 
Figure 2 shows cyclic voltammograms of different 
electrodes in 0.1 M PBS. The curve in Figure 2 shows the 
CV wave of bare gold electrode in PBS. Then, a well-
defined cyclic voltammogram with quasi-reversible redox 
waves can be observed at the anti-AFP-Fc/nano-
Au/MWCNTs/CS composite membrane modified Au 
electrode (Figure 2b), which indicated the 
electrochemical activity of the labeled Fc. For the BSA 
blocking with the modified electrode (Figure 2c), the peak 
currents decreased (against those of curve b). 
Subsequently, the immunosensor was incubated with 10 
ng/ml AFP standard sample solution; the curve d can be 
obtained. A further peak currents decrease of curve d 
indicates the formation of immunocomplex which could 
retard the electron transfer channels. 
In order to investigate the effect of MWCNTs, different 
kinds of composite membrane with and without, 
MWCNTs were used to modify the gold electrode. As can 
be clearly observed, the redox peak current of anti-AFP-
Fc/nano-Au/MWCNTs/CS composite membrane modified 
Au electrode (Figure 3a) is remarkably large compared 
with the anti-AFP-Fc/nano-Au/ CS composite solution 
coating electrode (Figure 3b), meaning the participating 
of MWCNTs added to the film may result to a large 
increase in the response which suggest that, MWCNTs 
modification leads to a higher electroactive area. 
 
 
Conditions optimization of immunoassay  
 
The effect  of  pH  on  the  amperometric  responses  was  
 






Figure 3. CVs of different electrodes constructed with anti-AFP-
Fc/nano-Au/MWCNTs/CS composite membrane (a) and anti-











examined in the pH range of 6.0 to 8.0. The current 
increased as the medium pH increased from 6.0 to 6.5 
and then, decreased at pH values higher than 7.0. It can 
be found that the responses at pH 6.5 and 7.0 have no 
significant difference. Thus, we chose pH 7.0 as the 
optimal pH in the further study. 
The temperature effect on the immunoreactions was 
studied. Briefly, the reaction of the immunosensor with 
AFP standard solution took place at the temperature of 
10 to 50°C for 15 min and then, its amperometric 
response was examined. The result shows that the 
immobilized anti-AFP exhibits the highest affinity towards 
AFP at 37°C (Figure 4a). Thus, 37°C was employed as 
the optimum incubation temperature in this study. 
The influence of immunoreaction time was also 
investigated. Using the AFP concentration of 10 ng/ml, 
the incubation times were 1, 2, 3, 5, 10 and 15 min, 
respectively. It was found that the amperometric response 
of the immunosensor decreased with incubation time 
rapidly up to first 6 min and then, the peak current 
decreased slowly at about 15 min (Figure 4b). Thus, 15 
min was adopted as the optimal incubation time for the 
immunoassay in the subsequent work. 
 
 
Performance of the immunosensor 
 
Calibration curve for AFP 
 
Based on the direct immunoassay protocol, the decrease  























Table 1. Comparison of different electrochemical immunosensors 
 
Detection methods Linear range (ng/ml) Detection limit (ng/ml) Reference 
Cyclic voltammetry 0.2–120.0 0.06 He et al. (2008) 
Cyclic voltammetry 1-55 0.6 Lin et al. ( 2009) 




Table 2. Comparison of serum AFP level determinations by using the two different methods. 
 
Serum sample ELISA (ng/ml) Proposed immunosensor (ng/ml) Relative deviation (%) 
1 6.24 6.47 -3.69 
2 9.87 10.55 -6.89 
3 36.10 35.12 2.71 
4 19.80 20.48 -3.43 




in amperometric response of the immunosensor was 
inversely related to the different concentration of AFP in 
standard sample. After the immunosensor was incubated 
in different concentration of AFP solution for 15 min at 
37°C; Figure 4 shows that the amperometric response 
was proportional to AFP concentration in two ranges from 
0.1 to 1.0 and 1.0 to 50 ng/ml, with the correlation 
coefficient of 0.9980 and 0.9975, respectively. A limit of 
detection of 0.03 ng/ml was calculated at signal-to-noise 





The performance of the immunosensor against 
interferences is important. Thus, the interference existing 
in real samples, such as carcinoembryonic antigen (10.0 
ng/ml), cancer antigen 125 (10.0 ng/ml), BSA (10.0 
ng/ml), were chosen to evaluate the specificity of the 
immunosensor. When the immunosensor was incubated 
with the AFP (10.0 ng/ml) solution contained the 
mentioned interference, no remarkable difference of peak 
currents was obtained when compared with the presence 
of only AFP (10.0 ng/ml). Thus, the immunosensor had a 
good selectivity to AFP. 
 
 
Regeneration and stability 
 
The regeneration performance of the prepared immune-
sensor was carried out using urea solution as 
regeneration solution to remove the target molecules 
(AFP) from the sensing layers. It was found that, the 
immunosensors could be regenerated by immersing in a 
4 M urea solution for about 20 min under stirring and 
then, rinsed thoroughly with PBS after each 
determination. The results show that it can be repeatedly 
used for 8 times without significant loss of detection 
sensitivity. 
Amperometric measurements were carried out with 7 
biosensors in a batch for the detection of 10 ng/ml AFP. 
With the relative standard deviation of 3.7%, 7 electrodes 
exhibited good reproducibility. The operational stability 
was also considered by continuous CV scans for 100 
circles. The relative deviation of the first circle and the 
100th circle was 3.92% showing good stability due to the 
fact that, the anti-AFP-Fc/nano-Au/MWCNTs/CS 
composite membrane may have a promising potential in 
fabricating the new kind of immunosensors based on 
indirect electrochemistry of immunomolecules. 
 
 
Performance comparison with different 
electrochemical immunosensors 
 
The performance of different electrochemical immune-
sensors has been compared with the present work. As 
shown in Table 1, the comparative data suggest 
superiority of the present sensor over some earlier 
reported immunosensor, especially the characteristics of 





In order to evaluate the validity of the proposed method, 
the fabricated immunosensors were used to determine 
the AFP in human serum samples. Furthermore, we 
compared the results obtained from 10 sera with this 
method and ELISA. Part of the results and the relative 










amperometric immunosensor based on anti-AFP-
Fc/nano-Au/MWCNTs/CS composite membrane in a 
direct and simple method. The direct detection of the 
immunosensor toward AFP has been obtained due to the 
direct amperometric responses decrease by antigen-
antibody immunocomplex generation which could 
obstruct the path of electron transfer. The immunosensor 
greatly simplified the immunoassay procedure with 
acceptable sensitivity. Meanwhile, the nano-
Au/MWCNTs/CS composite can efficiently retain the 





This work was financially supported by the Key Project 
from Chongqing Science and Technology Commission of 





Bad er D, Ri skin A, Va fsi O, Ta mir A, Pe skin B, Israel N, Merk sa mer 
R, Dar H, David M (2004). α-Fetoproeinin the early neonatal period: A 
large study and review of the literature. Clin. Chim. Acta. 349: 15-23. 
Brown KR, Walter DG, Natan MJ (2000). Seeding of colloidal Au 
nanoparticle solutions. 2. Improved control of particle size and shape. 
Chem. Mater. 12: 306-313. 
Grabar KC, Freeman RG, Hommer MB, Natan MJ (1995). Preparation 
and characterization of Au colloid monolayers. Anal. Chem. 67: 735-
743. 
He X-L, Yuan R, Chai Y-Q, Shi Y-T (2008). A sensitive amperometric 
immunosensor for carcinoembryonic antigen detection with porous 
nanogold film and nano-Au/chitosan composite as immobilization 





































Ji S-R, Liu C, Zhang B, Yang F, Xu J, Long J, Jin C, Fu D-L, Ni Q-X and 
Yu X-J (2010). Carbon nanotubes in cancer diagnosis and therapy. 
Biochim. Biophys. Acta 1806 :29-35. 
Kaminishi D, Ozaki H, Ohno Y, Maehashi K, Inoue K, Matsumoto K, Seri 
Y, Masuda A, Matsumura H (2005). Air-stable n-type carbon 
nanotube field-effect transistors with Si3N4 passivation films 
fabricated by catalytic chemical vapor deposition. Appl. Phys. Lett. 
86:113115-113117. 
Kumakura T, Tachibana K, Aoyagi S, Usuda S, Nakamura T, Miyakawa 
Y, Mayumi M (1983). Three-site sandwich radioimmunoassay with 
monoclonal antibodies for a sensitive determination of human 
alphafetoprotein. J. Immunol. Methods, 58: 293-300. 
Lin J-H, He C-Y, Zhang L-J, Zhang S-S (2009). Sensitive amperometric 
immunosensor for α-fetoprotein based on carbon nanotube/gold 
nanoparticle doped chitosan film. Anal. Biochem. 384(1):130-135. 
Luo J, Njoki PN, Lin Y, Mott D, Wang LJ, Zhong C (2006). 
Characterization of carbon-supported AuPt nanoparticles for 
electrocatalytic methanol oxidation reaction. Langmuir, 22: 2892-
2898. 
Mancal P, Srámek M, Malbohan I, Simek L (1988). The first clinical trial 
for determination of alpha-fetoprotein by means of Sevatest-ELISA 
AFP Kit (micro I), J. Hyg. Epidemiol. Microbiol. Immunol. 32: 209–
217. 
Ramanan RN, Ling TC, Tey BT, Ariff A B (2010). A simple method for 
quantification of interferon-2b through surface plasmon resonance 
technique Afr. J. Biotechnol. 9: 1680-1689. 
Shobha JDR, Sriman NS (2008). A novel nanobiocomposite based 
glucose biosensor using neutral red functionalized carbon nanotubes. 
Biosens. Bioelectron. 23 :1404-1411. 
Wang XW, Xie H (1999). Alpha-fetoprotein enhances the proliferation of 
human hepatoma cells in vitro. Life Sci. 64:17-23. 
Zhuo Y, Yuan P-X, Yuan R, Chai Y-Q, Hong C-L (2009). Bienzyme 
functionalized three-layer composite magnetic nanoparticles for 
electrochemical immunosensors. Biomaterials, 30 : 2284-2290. 
 
